88 related articles for article (PubMed ID: 2077697)
21. Altered properties of platelet membrane in childhood obesity.
Tangorra A; Ferretti G; Curatola G; Guerrieri A; Catassi C; Giorgi PL; Bertoli E
Biochem Int; 1988 Nov; 17(5):837-46. PubMed ID: 3254162
[TBL] [Abstract][Full Text] [Related]
22. Membrane fluidity of non-activated and activated human blood platelets.
Feijge MA; Heemskerk JW; Hornstra G
Biochim Biophys Acta; 1990 Jun; 1025(2):173-8. PubMed ID: 2364076
[TBL] [Abstract][Full Text] [Related]
23. Electroencephalographic correlates of increased platelet membrane fluidity in Alzheimer's disease.
Zubenko GS; Brenner RP; Teply I
Arch Neurol; 1988 Sep; 45(9):1009-13. PubMed ID: 3415519
[TBL] [Abstract][Full Text] [Related]
24. Cognitive function and platelet membrane fluidity in Alzheimer's disease.
Zubenko GS; Huff FJ; Becker J; Beyer J; Teply I
Biol Psychiatry; 1988 Dec; 24(8):925-36. PubMed ID: 3266076
[TBL] [Abstract][Full Text] [Related]
25. Platelet membrane fluidity in Alzheimer's disease and multi-infarct dementia: a spin label study.
Kaakkola S; Rosenberg PH; Alila A; Erkinjuntti T; Sulkava R; Palo J
Acta Neurol Scand; 1991 Jul; 84(1):18-21. PubMed ID: 1656688
[TBL] [Abstract][Full Text] [Related]
26. Docosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidity.
Hashimoto M; Hossain S; Shimada T; Shido O
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):934-9. PubMed ID: 17002670
[TBL] [Abstract][Full Text] [Related]
27. Platelet membrane fluidity individuals at risk for Alzheimer's disease: a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy.
Zubenko GS; Kopp U; Seto T; Firestone LL
Psychopharmacology (Berl); 1999 Jul; 145(2):175-80. PubMed ID: 10463318
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for stroke as predictors of platelet membrane fluidity in Alzheimer's disease.
Zubenko GS; Brenner RP; Teply I
Stroke; 1991 Aug; 22(8):997-1003. PubMed ID: 1866768
[TBL] [Abstract][Full Text] [Related]
29. S-adenosyl-L-methionine in the treatment of Alzheimer's disease.
Cohen BM; Satlin A; Zubenko GS
J Clin Psychopharmacol; 1988 Feb; 8(1):43-7. PubMed ID: 3350998
[TBL] [Abstract][Full Text] [Related]
30. Familial risk of dementia associated with a biologic subtype of Alzheimer's disease.
Zubenko GS; Huff FJ; Beyer J; Auerbach J; Teply I
Arch Gen Psychiatry; 1988 Oct; 45(10):889-93. PubMed ID: 3421803
[TBL] [Abstract][Full Text] [Related]
31. Lipid peroxidation and platelet membrane fluidity--implications for Alzheimer's disease?
van Rensburg SJ; Daniels WM; van Zyl J; Potocnik FC; van der Walt BJ; Taljaard JJ
Neuroreport; 1994 Nov; 5(17):2221-4. PubMed ID: 7881031
[TBL] [Abstract][Full Text] [Related]
32. Platelet membrane fluidity and Na+/K+ ATPase activity in acute stroke.
Nanetti L; Vignini A; Raffaelli F; Moroni C; Silvestrini M; Provinciali L; Mazzanti L
Brain Res; 2008 Apr; 1205():21-6. PubMed ID: 18343354
[TBL] [Abstract][Full Text] [Related]
33. Platelet membrane fluidity and intraplatelet Ca2+ homeostasis are affected in uremia.
Walkowiak B; Koziołkiewicz W; Michalec L; Borkowska E; Cierniewski CS
Pol J Pharmacol; 1996; 48(3):299-302. PubMed ID: 9112666
[TBL] [Abstract][Full Text] [Related]
34. Platelet membrane fluidity.
Zubenko GS
Neurology; 1993 Jan; 43(1):234-6. PubMed ID: 8423903
[No Abstract] [Full Text] [Related]
35. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.
Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS
Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794
[TBL] [Abstract][Full Text] [Related]
36. Temperature dependence of the molecular dynamics of platelet membranes in Alzheimer's disease.
Zubenko GS; Malinakova I; Cohen BM
Biol Psychiatry; 1987 Aug; 22(8):987-94. PubMed ID: 3607139
[TBL] [Abstract][Full Text] [Related]
37. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia.
Garzetti GG; Tranquilli AL; Cugini AM; Mazzanti L; Cester N; Romanini C
Obstet Gynecol; 1993 Mar; 81(3):337-40. PubMed ID: 8437781
[TBL] [Abstract][Full Text] [Related]
38. Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.
Zubenko GS; Teply I; Winwood E; Huff FJ; Moossy J; Sunderland T; Martinez AJ
Am J Psychiatry; 1996 Mar; 153(3):420-3. PubMed ID: 8610834
[TBL] [Abstract][Full Text] [Related]
39. Comparison of calcium, magnesium-ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls.
Miller MA; Sagnella GA; Markandu ND; MacGregor GA
J Hypertens; 1994 Aug; 12(8):929-38. PubMed ID: 7814852
[TBL] [Abstract][Full Text] [Related]
40. Modifications of platelet from Alzheimer disease patients: a possible relation between membrane properties and NO metabolites.
Vignini A; Nanetti L; Moroni C; Tanase L; Bartolini M; Luzzi S; Provinciali L; Mazzanti L
Neurobiol Aging; 2007 Jul; 28(7):987-94. PubMed ID: 16815594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
